Austrianova, a leading cell encapsulation company, announced today that it has been contracted by Nuvilex, Inc. to produce living encapsulated cells to cGMP (Good Manufacturing Practices) standard. The two companies signed a Manufacturing Framework Agreement that covers all aspects of the production of the encapsulated live cells. The encapsulated cells, also known as Cell-in-a-Box®, will be used for Nuvilex’s preclinical studies and clinical trials in patients with pancreatic cancer and other types of cancer.
GMP Production of Cell Banks, Fill and Finish and Cryopreservation of Cell and Cell-derived Products
Micro-encapsulation of living cells for immuno-protection and localization in patients